144 related articles for article (PubMed ID: 36440740)
1. Single-component lipid nanoparticles for engineering SOCS1 gene-silenced dendritic cells to boost tumor immunotherapy.
Yu Z; Wu M; Huang Y; Wang Y; Chen Y; Long Q; Lin Z; Xue L; Ju C; Zhang C
Biomater Sci; 2022 Dec; 11(1):263-277. PubMed ID: 36440740
[TBL] [Abstract][Full Text] [Related]
2. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
3. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
4. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
[TBL] [Abstract][Full Text] [Related]
5. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
6. A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.
Warashina S; Nakamura T; Sato Y; Fujiwara Y; Hyodo M; Hatakeyama H; Harashima H
J Control Release; 2016 Mar; 225():183-91. PubMed ID: 26820519
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
[TBL] [Abstract][Full Text] [Related]
8. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
[TBL] [Abstract][Full Text] [Related]
9. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
Jiang Q; Wang X; Qian M; Chen D; Xu Y
Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
[TBL] [Abstract][Full Text] [Related]
10. Silencing SOCS1 in dendritic cells promote survival of mice with systemic Candida albicans infection via inducing Th1-cell differentiation.
Shi D; Li D; Wang Q; Kong X; Mei H; Shen Y; Liu W
Immunol Lett; 2018 May; 197():53-62. PubMed ID: 29581081
[TBL] [Abstract][Full Text] [Related]
11. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus.
Zhu Y; Zheng Y; Mei L; Liu M; Li S; Xiao H; Zhu H; Wu S; Chen H; Huang L
Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
[TBL] [Abstract][Full Text] [Related]
13. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
[TBL] [Abstract][Full Text] [Related]
14. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.
Subramanya S; Armant M; Salkowitz JR; Nyakeriga AM; Haridas V; Hasan M; Bansal A; Goepfert PA; Wynn KK; Ladell K; Price DA; N M; Kan-Mitchell J; Shankar P
Mol Ther; 2010 Nov; 18(11):2028-37. PubMed ID: 20648001
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 1 (SOCS1) silencing and Hep-2 sensitizing dendritic cell vaccine in laryngocarcinoma immunotherapy.
Yuan Y; Li GY; Ji M; Zhang Y; Ding YP; Qi XC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5958-5966. PubMed ID: 31298347
[TBL] [Abstract][Full Text] [Related]
17. Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneously.
Zhang J; Yu J; Yang L; Li H; Wei F; Zhao H; Yu W; Ren X
Cancer Immunol Immunother; 2012 Oct; 61(10):1653-61. PubMed ID: 22366886
[TBL] [Abstract][Full Text] [Related]
18. Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells.
Yang R; Yang X; Zhang Z; Zhang Y; Wang S; Cai Z; Jia Y; Ma Y; Zheng C; Lu Y; Roden R; Chen Y
Gene Ther; 2006 Dec; 13(24):1714-23. PubMed ID: 16838032
[TBL] [Abstract][Full Text] [Related]
19. [Research of SOCS1 silent DC vaccine on laryngocarcinoma therapy].
Yuan Y; Wang XF; Zhang Y; Wang JY; Luan N
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Feb; 26(4):169-73. PubMed ID: 22568257
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection.
Srivastava V; Manchanda M; Gupta S; Singla R; Behera D; Das G; Natarajan K
J Biol Chem; 2009 Sep; 284(38):25532-41. PubMed ID: 19617348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
